3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
881
Neoplasms
668
Prostatic Neoplasms
455
Lung Neoplasms
368
Colorectal Neoplasms
335
Carcinoma, Non-Small-Cell Lung
320
Leukemia, Myeloid, Acute
257
Pancreatic Neoplasms
224
Brain Neoplasms
210
Multiple Myeloma
204
Neoplasm Metastasis
201
Carcinoma, Hepatocellular
184
Head and Neck Neoplasms
183
Glioblastoma
170
Precursor Cell Lymphoblastic Leukemia-Lymphoma
169
Melanoma
159
Ovarian Neoplasms
158
Squamous Cell Carcinoma of Head and Neck
152
Recurrence
139
Rectal Neoplasms
137
Hematologic Neoplasms
130
Sarcoma
126
Uterine Cervical Neoplasms
124
Stomach Neoplasms
118
Carcinoma, Renal Cell
118
Triple Negative Breast Neoplasms
116
Glioma
116
Motor Activity
105
Urinary Bladder Neoplasms
100
Myelodysplastic Syndromes
99
Interventions
durvalumab
1
Pemetrexed
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Non-Small Cell Lung Cancer Metastatic
×
90 days
×
Clear all
NCT04163432
2026-05-19
STAGGER
University of Utah
Phase 2
Active not recruiting
43 enrolled
12 charts